Am. J. Respir. Crit. Care Med.,
Volume 159, Number 5, May 1999, 1405-1411
Relationship between Resting Hypercapnia and
Physiologic Parameters before and after Lung
Volume Reduction Surgery in Severe Chronic
Obstructive Pulmonary Disease
DANIEL
SHADE Jr.,
FRANCIS
CORDOVA,
YAROSLAV
LANDO,
JOHN M.
TRAVALINE,
SATOSHI
FURUKAWA,
ANNE MARIE
KUZMA,
and
GERARD J.
CRINER
Division of Pulmonary and Critical Care Medicine, and Department of Surgery, Temple University School of Medicine,
Philadelphia, Pennsylvania
Patients with severe chronic obstructive pulmonary disease (COPD) have varying degrees of hypercapnia. Recent studies have demonstrated inconsistent effects of lung volume reduction surgery (LVRS) on PaCO2; however, most series have excluded patients with moderate to severe hypercapnia.
In addition, no study has examined the mechanisms responsible for the reduction in PaCO2 post-LVRS. We obtained spirometry, body plethysmography, diffusion capacity, respiratory muscle strength,
6-min walk test, and incremental symptom-limited maximal exercise data in 33 consecutive patients pre- and 3 to 6 mo post-LVRS, and explored the relationship between changes in PaCO2 and changes
in the measured physiologic variables. All patients underwent bilateral LVRS via median sternotomy
and stapling resection by the same cardiothoracic surgeon. Patients were 57 ± 8 yr of age with severe COPD, hyperinflation, and air trapping (FEV1, 0.73 ± 0.2 L; TLC, 7.3 ± 1.6 L; residual volume [RV],
4.8 ± 1.4 L), and moderate resting hypercapnia (PaCO2, 44 ± 7 mm Hg; range, 32 to 56 mm Hg). Post-LVRS, PaCO2 decreased by 4% (PaCO2 pre 44 ± 7 mm Hg, PaCO2 post 42 ± 5 mm Hg; p = 0.003). Patients with higher baseline values of PaCO2 had the greatest reduction in PaCO2 post-LVRS (r =
0.61,
p < 0.001). Significant correlations existed between reduction in PaCO2 and changes in FEV1 (r =
0.56; p = 0.0007), maximal inspiratory pressure (PImax) (r =
0.46; p = 0.009), diffusing capacity of
the lungs for carbon monoxide (DLCO) (r =
0.47; p = 0.008), and RV/TLC (r = 0.41; p = 0.02). Correlation existed also between reduction in PaCO2 and breathing pattern at maximal exercise: maximal
minute ventilation (
Emax) (r =
0.47; p = 0.009), and tidal volume (VT) (r =
0.40; p = 0.02). The
changes in PaCO2 post-LVRS showed marked intersubject variability. We conclude that LVRS, by reducing hyperinflation, air trapping, and improving respiratory muscle function, enables the lung and
chest wall to act more effectively as a pump, thereby increasing alveolar ventilation and reducing
baseline resting PaCO2. In addition, patients with higher baseline levels of PaCO2 demonstrate the
greatest reduction in PaCO2 post-LVRS, and should not be excluded from receiving LVRS.